(Q35534829)

8 August 2017

title

Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis (English)

1 reference

ORCID Public Data File 2021

8 August 2017

0 references

1 reference

author name string

Suri R

1

1 reference

8 August 2017

Grieve R

2

1 reference

8 August 2017

Normand C

3

1 reference

8 August 2017

Metcalfe C

4

1 reference

8 August 2017

Thompson S

5

1 reference

8 August 2017

Wallis C

6

1 reference

8 August 2017

Bush A

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

8 August 2017

1 reference

8 August 2017

volume

57

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

841-846

1 reference

How should cost data in pragmatic randomised trials be analysed?

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Assessing the costs of healthcare technologies in clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Retrospective review of the effects of rhDNase in children with cystic fibrosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Consensus conference: practical applications of Pulmozyme. September 22, 1993.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Effects of Recombinant Human DNase Therapy on Healthcare use and Costs in Patients with Cystic Fibrosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746194

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis

26 September 2018

1 reference

12 December 2020

A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis

1 reference

12 December 2020

Handling uncertainty when performing economic evaluation of healthcare interventions

1 reference

12 December 2020

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis

1 reference

12 December 2020

Use of rhDNase therapy and costs of respiratory-related care in patients with cystic fibrosis

1 reference

12 December 2020

Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial

1 reference

12 December 2020

The quality of well-being in cystic fibrosis

1 reference

12 December 2020

The changing epidemiology of cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/THORAX.57.10.841

1 reference

8 August 2017

1 reference

8 August 2017

1 reference